Minimally Invasive Fat Reduction Device Market Size, Share & Trends Analysis - Global - 2023-2029 - MedCore - Includes: Cryolipolysis Device, Ultrasound Lipolysis Device

Minimally Invasive Fat Reduction Device Market Size, Share & Trends Analysis - Global - 2023-2029 - MedCore - Includes: Cryolipolysis Device, Ultrasound Lipolysis Device

The global market for minimally invasive fat reduction devices was valued at $651.3 million in 2022, with a projected CAGR of 4.7% over the forecast period leading to an estimated value of $897.1 million.

The complete report suite for the global minimally invasive fat reduction device market includes cryolipolysis devices, ultrasound lipolysis devices, laser lipolysis devices, and Kybella® injection segments. Procedure data is further classified into Kybella® injection and non-injectable fat reduction procedures.

MARKET DATA INCLUDED

Unit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers

COVID-19 Impact Analysis

Market Drivers & Limiters
Market Forecasts Until 2029, and Historical Data to 2019
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors

GLOBAL MINIMALLY INVASIVE FAT REDUCTION DEVICE MARKET INSIGHTS

Research and development, coupled with the increasing adoption of relevant technologies, have led to the growing popularity of minimally and non-invasive fat reduction methods. The rising awareness of weight management, combined with social media's promotion of the ideal body image, has further fueled the demand for safe and effective fat removal procedures. As a result, the fat reduction procedure volume is expected to continue its growth trajectory, leading to increased sales in the adjustment device market.

GLOBAL MINIMALLY INVASIVE FAT REDUCTION DEVICE MARKET SHARE INSIGHTS

The global minimally invasive fat reduction device market was dominated by Allergan, Merz Aesthetics, and Cynosure.
In 2022, Allergan, a subsidiary of AbbVie, held the top position in the global minimally invasive fat reduction device market. Allergan's CoolSculpting® machine is the sole cryolipolysis machine with FDA approval, giving the company a substantial market share in this segment. Additionally, Allergan also owns Kybella® (deoxycholic acid), known as Belkyra® in Europe, further cementing its dominance in this market.

MARKET SEGMENTATION SUMMARY

Cryolipolysis Device Market
Ultrasound Lipolysis Device Market
Laser Lipolysis Device Market
Kybella® Injection Market

RESEARCH SCOPE SUMMARY
Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2022
Forecast Period: 2023-2029
Historical Data: 2019-2022
Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices
Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Read more about iData’s 9-Step Research Methodology

WHY CHOOSE IDATA?

Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavor never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.